Simplify Genomics and SimonMed Announce Collaboration to Advance Preventive Healthcare Through Integrated Genomics and Imaging
Combining whole genome interpretation with large-scale whole-body MRI to enable a more comprehensive view of human health
San Diego, CA — June 30, 2026 — Simplify Genomics today announced a collaboration with SimonMed aimed at advancing a more integrated approach to preventive healthcare. By combining SimonMed’s national scale in whole-body MRI with Simplify’s Whole Genome Interpretation and Reporting Platform, the collaboration seeks to provide a more complete picture of human health— helping identify risk earlier, personalize care pathways, and support more proactive health decisions. Across both imaging and genomics, there is growing evidence that early indicators associated with disease may be identified well before they surface in traditional care pathways. Together, these modalities offer complementary perspectives: genomics can provide insight into underlying disease risk, while imaging can help identify existing structural or physiological changes.
Simplify Genomics has spent years developing and refining its clinical reporting platform as a CAP/CLIA-certified laboratory and has processed in excess of 50,000 whole genomes to date. The platform includes thousands of disease associations and a broad set of pharmacogenomic insights, designed to support clinical interpretation and integration within real-world care settings.
Paired with SimonMed’s leadership in accessible, AI-enhanced imaging at national scale—including a network of more than 175 imaging centers across the United States —the collaboration creates an opportunity to explore patterns and connections that may not be visible through any single modality alone, supporting earlier insight and helping to inform clinical decision-making.
“This collaboration reflects a shared vision for the future of healthcare—one that is more proactive, data-driven, and personalized,” said Travis Lacey, CEO of Simplify Genomics.
“We believe the future of healthcare lies in making advanced preventive insights more accessible and actionable,” said John Simon, CEO of SimonMed. “By combining imaging and genomics, we have an opportunity to help patients and providers better understand health risk earlier and with greater clarity.” The collaboration is progressing rapidly, with additional updates expected in the near future.
